|
FLUOROURACIL TOXICITY IS ENHANCED WITH COMCOMITANT USE
|
CIMETIDINE INCREASES ITS PLASMA CONCENTRATION AND HENCE BIOAVAILABILITY
|
VACCINATION WITH LIVE VIRUS / BACTERIA MAY CAUSE LIFE THREATENING COMPLICATIONS DUE TO POOR BODY IMMUNITY
|
VACCINATION WITH LIVE VIRUS / BACTERIA MAY CAUSE LIFE THREATENING COMPLICATIONS DUE TO POOR BODY IMMUNITY
|
VACCINATION WITH LIVE VIRUS / BACTERIA MAY CAUSE LIFE THREATENING COMPLICATIONS DUE TO POOR BODY IMMUNITY
|
VACCINATION WITH LIVE VIRUS / BACTERIA MAY CAUSE LIFE THREATENING COMPLICATIONS DUE TO POOR BODY IMMUNITY
|
VACCINATION WITH LIVE VIRUS / BACTERIA MAY CAUSE LIFE THREATENING COMPLICATIONS DUE TO POOR BODY IMMUNITY
|
VACCINATION WITH LIVE VIRUS / BACTERIA MAY CAUSE LIFE THREATENING COMPLICATIONS DUE TO POOR BODY IMMUNITY
|
VACCINATION WITH LIVE VIRUS / BACTERIA MAY CAUSE LIFE THREATENING COMPLICATIONS DUE TO POOR BODY IMMUNITY
|
VACCINATION WITH LIVE VIRUS / BACTERIA MAY CAUSE LIFE THREATENING COMPLICATIONS DUE TO POOR BODY IMMUNITY
|
VACCINATION WITH LIVE VIRUS / BACTERIA MAY CAUSE LIFE THREATENING COMPLICATIONS DUE TO POOR BODY IMMUNITY
|
VACCINATION WITH LIVE VIRUS / BACTERIA MAY CAUSE LIFE THREATENING COMPLICATIONS DUE TO POOR BODY IMMUNITY
|
VACCINATION WITH LIVE VIRUS / BACTERIA MAY CAUSE LIFE THREATENING COMPLICATIONS DUE TO POOR BODY IMMUNITY
|
VACCINATION WITH LIVE VIRUS / BACTERIA MAY CAUSE LIFE THREATENING COMPLICATIONS DUE TO POOR BODY IMMUNITY
|
ADDITIVE MYELOSUPPRESSION WHEN USED WITH OTHER MYELOSUPPRESSIVE DRUGS
|
ADDITIVE MYELOSUPPRESSION WHEN USED WITH OTHER MYELOSUPPRESSIVE DRUGS
|
ADDITIVE MYELOSUPPRESSION WHEN USED WITH OTHER MYELOSUPPRESSIVE DRUGS
|
ADDITIVE MYELOSUPPRESSION WHEN USED WITH OTHER MYELOSUPPRESSIVE DRUGS
|
ADDITIVE MYELOSUPPRESSION WHEN USED WITH OTHER MYELOSUPPRESSIVE DRUGS
|
ADDITIVE MYELOSUPPRESSION WHEN USED WITH OTHER MYELOSUPPRESSIVE DRUGS
|
ADDITIVE MYELOSUPPRESSION WHEN USED WITH OTHER MYELOSUPPRESSIVE DRUGS
|
ADDITIVE MYELOSUPPRESSION WHEN USED WITH OTHER MYELOSUPPRESSIVE DRUGS
|
ADDITIVE MYELOSUPPRESSION WHEN USED WITH OTHER MYELOSUPPRESSIVE DRUGS
|
ADDITIVE MYELOSUPPRESSION WHEN USED WITH OTHER MYELOSUPPRESSIVE DRUGS
|
ADDITIVE MYELOSUPPRESSION WHEN USED WITH OTHER MYELOSUPPRESSIVE DRUGS
|
ADDITIVE MYELOSUPPRESSION WHEN USED WITH OTHER MYELOSUPPRESSIVE DRUGS
|
ADDITIVE MYELOSUPPRESSION WHEN USED WITH OTHER MYELOSUPPRESSIVE DRUGS
|
ADDITIVE MYELOSUPPRESSION WHEN USED WITH OTHER MYELOSUPPRESSIVE DRUGS
|
CONCURRENT USE MAY ENHANCE THE POTENTIAL FOR RENAL TOXICITY, BRONCHOSPASM, AND HYPOTENSION
|
POTENTIAL FOR INCREASED MYELOTOXICITY AND NEPHROTOXICITY
|
DRUGS CAUSING MYELOSUPPRESSION CAN EXACERBATE THE EFFECTS OF INTERFERON
|
DRUGS CAUSING MYELOSUPPRESSION CAN EXACERBATE THE EFFECTS OF INTERFERON
|
DRUGS CAUSING MYELOSUPPRESSION CAN EXACERBATE THE EFFECTS OF INTERFERON
|
DRUGS CAUSING MYELOSUPPRESSION CAN EXACERBATE THE EFFECTS OF INTERFERON
|
DRUGS CAUSING MYELOSUPPRESSION CAN EXACERBATE THE EFFECTS OF INTERFERON
|
DRUGS CAUSING MYELOSUPPRESSION CAN EXACERBATE THE EFFECTS OF INTERFERON
|
DRUGS CAUSING MYELOSUPPRESSION CAN EXACERBATE THE EFFECTS OF INTERFERON
|
DRUGS CAUSING MYELOSUPPRESSION CAN EXACERBATE THE EFFECTS OF INTERFERON
|
BUSULFAN-INDUCED PULMONARY TOXICITY MAY BE ADDITIVE TO THE EFFECTS PRODUCED BY OTHER CYTOTOXIC AGENTS
|
ZIDOVUDINE HEMATOLOGIC TOXICITY IS INCREASED BY THE CYTOTOXIC DRUGS
|
INCREASED RISK OF BONE MARROW SUPPRESSION
|
FOLIC ACID DEFICIENCY MAY PRECIPITATE WITH CONCURRENT USE
|
METRONIDAZOLE IMPAIRES CLEARANCE OF THE DRUG
|
SECNIDAZOLE IMPAIRES METABOLISM OR INCREASE EXCRETION OF THE DRUG
|
SECNIDAZOLE IMPAIRES METABOLISM OR INCREASE EXCRETION OF THE DRUG
|
SECNIDAZOLE IMPAIRES METABOLISM OR INCREASE EXCRETION OF THE DRUG
|
SECNIDAZOLE IMPAIRES METABOLISM OR INCREASE EXCRETION OF THE DRUG
|
VACCINES HAVE POOR RESULT IF GIVEN DURING THE DRUG THERAPY
|
VACCINES HAVE POOR RESULT IF GIVEN DURING THE DRUG THERAPY
|
VACCINES HAVE POOR RESULT IF GIVEN DURING THE DRUG THERAPY
|
VACCINES HAVE POOR RESULT IF GIVEN DURING THE DRUG THERAPY
|
VACCINES HAVE POOR RESULT IF GIVEN DURING THE DRUG THERAPY
|
VACCINES HAVE POOR RESULT IF GIVEN DURING THE DRUG THERAPY
|
VACCINES HAVE POOR RESULT IF GIVEN DURING THE DRUG THERAPY
|
VACCINES HAVE POOR RESULT IF GIVEN DURING THE DRUG THERAPY
|
VACCINES HAVE POOR RESULT IF GIVEN DURING THE DRUG THERAPY
|
VACCINES HAVE POOR RESULT IF GIVEN DURING THE DRUG THERAPY
|
VACCINES HAVE POOR RESULT IF GIVEN DURING THE DRUG THERAPY
|
VACCINES HAVE POOR RESULT IF GIVEN DURING THE DRUG THERAPY
|
VACCINES HAVE POOR RESULT IF GIVEN DURING THE DRUG THERAPY
|
VACCINES HAVE POOR RESULT IF GIVEN DURING THE DRUG THERAPY
|
VACCINES HAVE POOR RESULT IF GIVEN DURING THE DRUG THERAPY
|
VACCINES HAVE POOR RESULT IF GIVEN DURING THE DRUG THERAPY
|
VACCINES HAVE POOR RESULT IF GIVEN DURING THE DRUG THERAPY
|
INCREASES TOXICITY AS WELL AS ANTINEOPLASTIC ACTION ESPECIALLY ON GI TRACT
|
INCREASES TOXICITY AS WELL AS ANTINEOPLASTIC ACTION ESPECIALLY ON GI TRACT
|